Introduction The immunogenicity and safety of one dose of Tdap-IPV (tetanus, diphtheria,
acellular pertussis and inactivated poliomyelitis vaccine) and two doses of Td-IPV (tetanus …

BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …

Many countries recommend diphtheria, tetanus and/or poliomyelitis boosters in adolescents
or adults and the need for pertussis booster vaccination beyond childhood is increasingly …

Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …

Background Pertussis in adults and adolescents could be reduced by replacing traditional
tetanus and diphtheria (Td) boosters with reduced-antigen-content diphtheria–tetanus …

At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …

Background. Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine
(Tdap) in persons aged≥ 65 years are limited. This study aims to examine a large cohort of …

This study was to assess the humoral immune response induced by a vaccination schedule
routinely used in France in 18-50 year old adults with unknown vaccination history. In this …

Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …

Background: The rising incidence of pertussis amongst adults and adolescents in
industrialised countries could be reduced by replacing tetanus and diphtheria (Td) boosters …